Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.72 – $5.23
9% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.97B | $22.42B | $24.04B | $26.15B | $31.65B | $36.21B | $37.42B | $38.55B |
| Cost of revenue | $12.72B | $13.79B | $15.05B | $16.50B | $20.44B | $22.13B | $22.46B | $23.02B |
| Gross profit | $8.25B | $8.63B | $8.99B | $9.65B | $11.21B | $14.08B | $14.96B | $15.53B |
| Gross margin | 39.3% | 38.5% | 37.4% | 36.9% | 35.4% | 38.9% | 40.0% | 40.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $3.00B | $2.99B | $3.25B | $3.01B | $3.83B | $5.02B | $5.28B | $5.53B |
| EBITDA | $4.54B | $4.71B | $5.19B | $4.89B | $5.69B | $7.33B | $7.22B | $6.56B |
| Net income | $1.16B | $1.01B | $828.0M | $725.7M | $776.6M | $1.32B | $1.36B | $1.78B |
| Net margin | 5.5% | 4.5% | 3.4% | 2.8% | 2.5% | 3.6% | 3.6% | 4.6% |
| EPS (diluted) | 2.72 | 2.48 | 2.17 | 2.02 | 2.28 | 3.98 | 4.19 | 5.55 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $35.0B | $6.31 | $6.31–$6.31 | 1 |
| 2027 | $25.3B | $8.66 | $8.66–$8.66 | 1 |
| 2028 | $25.3B | $8.66 | $8.66–$8.66 | 1 |
Forward consensus · source: Financial Modeling Prep
GRUPO HERDEZ SA CV ORD
No one on the platform currently holds GUZOF.
No tracked institution reports a position in GUZOF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-10-12 | $0.7500 | 2026-10-13 |
| 2026-05-11 | $0.7500 | 2026-05-12 |
| 2026-04-13 | $15.0000 | 2026-04-14 |
| 2025-10-06 | $0.7500 | 2025-10-07 |
| 2025-05-05 | $1.0000 | 2025-05-06 |
| 2025-05-05 | $0.7500 | 2025-05-06 |
| 2024-05-09 | $0.7500 | 2024-05-13 |
No one on the platform has traded GUZOF yet.
| +0.00% |
| $650M |
| — |
| JWLLFJamieson Wellness Inc. | $28.92 | +0.00% | $1.2B | — |
| PGENYPigeon Corporation | $3.10 | +0.00% | $1.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.7× earnings vs its 0.6× historical median P/E.
Fair value ≈ $2.84 · price $2.94 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.